SHEKHAR, Shashank,FRANCZYK,Thaddeus S.,BARNES, David M.,DUNN, Travis B.,HAIGHT, Anthony R.,CHAN, Vincent S.
申请号：
MYPI 2013700083
公开号：
MY167881A
申请日:
2011.07.15
申请国别(地区):
MY
年份:
2018
代理人:
摘要：
This disclosure is directed to: (a) processes for preparing a compound and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV)； (b) intermediates useful for the preparation of the compound and salts； (c) pharmaceutical compositions comprising the compound or salts； and (d) methods of use of such compositions.
